US Stock MarketDetailed Quotes

A Agilent Technologies

Watchlist
  • 132.320
  • -2.170-1.61%
Trading Nov 26 14:49 ET
37.74BMarket Cap29.87P/E (TTM)

Agilent Technologies Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Oct 31, 2024
(Q4)Oct 31, 2024
(Q3)Jul 31, 2024
(Q2)Apr 30, 2024
(Q1)Jan 31, 2024
(FY)Oct 31, 2023
(Q4)Oct 31, 2023
(Q3)Jul 31, 2023
(Q2)Apr 30, 2023
(Q1)Jan 31, 2023
Assets
Current assets
Cash, cash equivalents and short term investments
-16.42%1.33B
-16.42%1.33B
33.86%1.78B
42.21%1.67B
39.84%1.75B
51.00%1.59B
51.00%1.59B
23.40%1.33B
-2.65%1.18B
7.94%1.25B
-Cash and cash equivalents
-16.42%1.33B
-16.42%1.33B
33.86%1.78B
42.21%1.67B
39.84%1.75B
51.00%1.59B
51.00%1.59B
24.09%1.33B
-0.93%1.18B
12.31%1.25B
Receivables
2.56%1.32B
2.56%1.32B
-8.36%1.23B
-10.85%1.25B
-11.24%1.3B
-8.11%1.29B
-8.11%1.29B
-0.45%1.34B
13.26%1.4B
21.08%1.46B
-Accounts receivable
2.56%1.32B
2.56%1.32B
-26.59%983M
-28.12%1.01B
-11.24%1.3B
-8.11%1.29B
-8.11%1.29B
-0.45%1.34B
13.26%1.4B
21.08%1.46B
-Other receivables
----
----
--244M
--242M
----
----
----
----
----
----
Inventory
-5.72%972M
-5.72%972M
-8.77%978M
-9.34%1B
-7.02%1.03B
-0.67%1.03B
-0.67%1.03B
6.14%1.07B
17.72%1.1B
26.39%1.11B
Restricted cash
----
----
----
----
----
----
----
----
--3M
----
Other current assets
21.90%334M
21.90%334M
-6.21%272M
5.99%283M
1.55%262M
-2.84%274M
-2.84%274M
12.40%290M
1.91%267M
11.21%258M
Total current assets
-5.42%3.96B
-5.42%3.96B
5.61%4.26B
6.43%4.2B
6.38%4.34B
10.80%4.19B
10.80%4.19B
9.21%4.03B
8.40%3.95B
17.39%4.08B
Non current assets
Net PPE
40.00%1.78B
40.00%1.78B
19.41%1.45B
15.79%1.37B
14.56%1.31B
15.45%1.27B
15.45%1.27B
14.90%1.21B
17.23%1.18B
17.76%1.15B
-Gross PPE
----
----
----
----
----
10.90%2.49B
10.90%2.49B
----
----
----
-Accumulated depreciation
----
----
----
----
----
-6.53%-1.22B
-6.53%-1.22B
----
----
----
Goodwill and other intangible assets
13.28%5.02B
13.28%5.02B
-2.88%4.36B
-8.77%4.38B
-7.99%4.41B
-7.08%4.44B
-7.08%4.44B
-6.48%4.49B
-1.09%4.8B
-2.04%4.79B
-Goodwill
13.06%4.48B
13.06%4.48B
-0.48%3.97B
-0.43%3.96B
-0.40%3.97B
0.20%3.96B
0.20%3.96B
0.91%3.98B
0.61%3.98B
0.48%3.98B
-Other intangible assets
15.16%547M
15.16%547M
-21.91%392M
-49.21%417M
-45.31%443M
-42.14%475M
-42.14%475M
-40.87%502M
-8.57%821M
-12.81%810M
Investments and advances
6.71%175M
6.71%175M
-2.11%186M
-4.84%177M
-9.57%170M
-15.90%164M
-15.90%164M
-2.06%190M
-2.11%186M
-1.57%188M
Other non current assets
28.53%910M
28.53%910M
-0.92%751M
4.32%725M
0.42%716M
3.21%708M
3.21%708M
1.20%758M
-8.31%695M
-10.31%713M
Total non current assets
19.92%7.89B
19.92%7.89B
1.43%6.74B
-3.10%6.65B
-3.38%6.61B
-2.62%6.58B
-2.62%6.58B
-2.19%6.65B
0.79%6.87B
-0.18%6.84B
Total assets
10.06%11.85B
10.06%11.85B
3.01%11B
0.59%10.86B
0.27%10.95B
2.19%10.76B
2.19%10.76B
1.82%10.68B
3.22%10.79B
5.73%10.92B
Liabilities
Current liabilities
Payables
29.19%540M
29.19%540M
9.96%497M
-3.76%461M
-9.63%488M
-27.93%418M
-27.93%418M
-19.00%452M
-4.77%479M
13.68%540M
-accounts payable
29.19%540M
29.19%540M
9.96%497M
-3.76%461M
-9.63%488M
-27.93%418M
-27.93%418M
-19.00%452M
-4.77%479M
13.68%540M
Current accrued expenses
28.80%398M
28.80%398M
-35.61%264M
-29.45%218M
-1.76%335M
-6.08%309M
-6.08%309M
48.01%410M
11.55%309M
4.60%341M
Current debt and capital lease obligation
--45M
--45M
1,345.45%795M
--420M
----
----
----
-69.44%55M
----
--238M
-Current debt
--45M
--45M
1,345.45%795M
--420M
----
----
----
-69.44%55M
----
--238M
Current deferred liabilities
7.72%544M
7.72%544M
2.34%524M
2.70%533M
0.19%522M
9.54%505M
9.54%505M
2.81%512M
1.57%519M
5.68%521M
Current liabilities
18.22%1.9B
18.22%1.9B
35.74%2.39B
17.53%1.96B
-16.48%1.62B
-13.86%1.6B
-13.86%1.6B
-7.47%1.76B
-8.11%1.67B
22.22%1.94B
Non current liabilities
Long term debt and capital lease obligation
22.30%3.35B
22.30%3.35B
-21.84%2.14B
-21.84%2.14B
-6.51%2.56B
0.07%2.74B
0.07%2.74B
0.07%2.73B
0.11%2.73B
0.11%2.73B
-Long term debt
22.30%3.35B
22.30%3.35B
-21.84%2.14B
-21.84%2.14B
-6.51%2.56B
0.07%2.74B
0.07%2.74B
0.07%2.73B
0.11%2.73B
0.11%2.73B
Employee benefits
26.21%130M
26.21%130M
4.35%96M
2.06%99M
3.03%102M
6.19%103M
6.19%103M
-47.73%92M
-48.13%97M
-51.94%99M
Other non current liabilities
21.17%578M
21.17%578M
-11.30%471M
-12.82%449M
-10.33%486M
-11.01%477M
-11.01%477M
-8.92%531M
-14.59%515M
-17.00%542M
Total non current liabilities
22.26%4.05B
22.26%4.05B
-19.45%2.7B
-19.76%2.68B
-6.85%3.14B
-1.52%3.32B
-1.52%3.32B
-3.84%3.36B
-4.97%3.35B
-5.99%3.37B
Total liabilities
20.94%5.95B
20.94%5.95B
-0.47%5.09B
-7.36%4.64B
-10.36%4.76B
-5.91%4.92B
-5.91%4.92B
-5.12%5.12B
-6.04%5.01B
2.65%5.31B
Shareholders'equity
Share capital
0.00%3M
0.00%3M
0.00%3M
0.00%3M
0.00%3M
0.00%3M
0.00%3M
0.00%3M
0.00%3M
0.00%3M
-common stock
0.00%3M
0.00%3M
0.00%3M
0.00%3M
0.00%3M
0.00%3M
0.00%3M
0.00%3M
0.00%3M
0.00%3M
-Preferred stock
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Retained earnings
-4.09%750M
-4.09%750M
74.10%773M
55.71%1.09B
96.12%1.06B
141.36%782M
141.36%782M
219.42%444M
337.50%700M
240.25%541M
Paid-in capital
1.17%5.45B
1.17%5.45B
1.41%5.46B
1.83%5.46B
1.78%5.44B
1.16%5.39B
1.16%5.39B
1.34%5.38B
1.28%5.36B
1.04%5.35B
Gains losses not affecting retained earnings
6.73%-305M
6.73%-305M
-22.14%-331M
-19.50%-337M
-12.86%-316M
5.76%-327M
5.76%-327M
25.14%-271M
15.32%-282M
6.04%-280M
Total stockholders'equity
0.91%5.9B
0.91%5.9B
6.21%5.9B
7.49%6.21B
10.32%6.19B
10.18%5.85B
10.18%5.85B
9.17%5.56B
12.87%5.78B
8.83%5.61B
Total equity
0.91%5.9B
0.91%5.9B
6.21%5.9B
7.49%6.21B
10.32%6.19B
10.18%5.85B
10.18%5.85B
9.17%5.56B
12.87%5.78B
8.83%5.61B
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Oct 31, 2024(Q4)Oct 31, 2024(Q3)Jul 31, 2024(Q2)Apr 30, 2024(Q1)Jan 31, 2024(FY)Oct 31, 2023(Q4)Oct 31, 2023(Q3)Jul 31, 2023(Q2)Apr 30, 2023(Q1)Jan 31, 2023
Assets
Current assets
Cash, cash equivalents and short term investments -16.42%1.33B-16.42%1.33B33.86%1.78B42.21%1.67B39.84%1.75B51.00%1.59B51.00%1.59B23.40%1.33B-2.65%1.18B7.94%1.25B
-Cash and cash equivalents -16.42%1.33B-16.42%1.33B33.86%1.78B42.21%1.67B39.84%1.75B51.00%1.59B51.00%1.59B24.09%1.33B-0.93%1.18B12.31%1.25B
Receivables 2.56%1.32B2.56%1.32B-8.36%1.23B-10.85%1.25B-11.24%1.3B-8.11%1.29B-8.11%1.29B-0.45%1.34B13.26%1.4B21.08%1.46B
-Accounts receivable 2.56%1.32B2.56%1.32B-26.59%983M-28.12%1.01B-11.24%1.3B-8.11%1.29B-8.11%1.29B-0.45%1.34B13.26%1.4B21.08%1.46B
-Other receivables ----------244M--242M------------------------
Inventory -5.72%972M-5.72%972M-8.77%978M-9.34%1B-7.02%1.03B-0.67%1.03B-0.67%1.03B6.14%1.07B17.72%1.1B26.39%1.11B
Restricted cash ----------------------------------3M----
Other current assets 21.90%334M21.90%334M-6.21%272M5.99%283M1.55%262M-2.84%274M-2.84%274M12.40%290M1.91%267M11.21%258M
Total current assets -5.42%3.96B-5.42%3.96B5.61%4.26B6.43%4.2B6.38%4.34B10.80%4.19B10.80%4.19B9.21%4.03B8.40%3.95B17.39%4.08B
Non current assets
Net PPE 40.00%1.78B40.00%1.78B19.41%1.45B15.79%1.37B14.56%1.31B15.45%1.27B15.45%1.27B14.90%1.21B17.23%1.18B17.76%1.15B
-Gross PPE --------------------10.90%2.49B10.90%2.49B------------
-Accumulated depreciation ---------------------6.53%-1.22B-6.53%-1.22B------------
Goodwill and other intangible assets 13.28%5.02B13.28%5.02B-2.88%4.36B-8.77%4.38B-7.99%4.41B-7.08%4.44B-7.08%4.44B-6.48%4.49B-1.09%4.8B-2.04%4.79B
-Goodwill 13.06%4.48B13.06%4.48B-0.48%3.97B-0.43%3.96B-0.40%3.97B0.20%3.96B0.20%3.96B0.91%3.98B0.61%3.98B0.48%3.98B
-Other intangible assets 15.16%547M15.16%547M-21.91%392M-49.21%417M-45.31%443M-42.14%475M-42.14%475M-40.87%502M-8.57%821M-12.81%810M
Investments and advances 6.71%175M6.71%175M-2.11%186M-4.84%177M-9.57%170M-15.90%164M-15.90%164M-2.06%190M-2.11%186M-1.57%188M
Other non current assets 28.53%910M28.53%910M-0.92%751M4.32%725M0.42%716M3.21%708M3.21%708M1.20%758M-8.31%695M-10.31%713M
Total non current assets 19.92%7.89B19.92%7.89B1.43%6.74B-3.10%6.65B-3.38%6.61B-2.62%6.58B-2.62%6.58B-2.19%6.65B0.79%6.87B-0.18%6.84B
Total assets 10.06%11.85B10.06%11.85B3.01%11B0.59%10.86B0.27%10.95B2.19%10.76B2.19%10.76B1.82%10.68B3.22%10.79B5.73%10.92B
Liabilities
Current liabilities
Payables 29.19%540M29.19%540M9.96%497M-3.76%461M-9.63%488M-27.93%418M-27.93%418M-19.00%452M-4.77%479M13.68%540M
-accounts payable 29.19%540M29.19%540M9.96%497M-3.76%461M-9.63%488M-27.93%418M-27.93%418M-19.00%452M-4.77%479M13.68%540M
Current accrued expenses 28.80%398M28.80%398M-35.61%264M-29.45%218M-1.76%335M-6.08%309M-6.08%309M48.01%410M11.55%309M4.60%341M
Current debt and capital lease obligation --45M--45M1,345.45%795M--420M-------------69.44%55M------238M
-Current debt --45M--45M1,345.45%795M--420M-------------69.44%55M------238M
Current deferred liabilities 7.72%544M7.72%544M2.34%524M2.70%533M0.19%522M9.54%505M9.54%505M2.81%512M1.57%519M5.68%521M
Current liabilities 18.22%1.9B18.22%1.9B35.74%2.39B17.53%1.96B-16.48%1.62B-13.86%1.6B-13.86%1.6B-7.47%1.76B-8.11%1.67B22.22%1.94B
Non current liabilities
Long term debt and capital lease obligation 22.30%3.35B22.30%3.35B-21.84%2.14B-21.84%2.14B-6.51%2.56B0.07%2.74B0.07%2.74B0.07%2.73B0.11%2.73B0.11%2.73B
-Long term debt 22.30%3.35B22.30%3.35B-21.84%2.14B-21.84%2.14B-6.51%2.56B0.07%2.74B0.07%2.74B0.07%2.73B0.11%2.73B0.11%2.73B
Employee benefits 26.21%130M26.21%130M4.35%96M2.06%99M3.03%102M6.19%103M6.19%103M-47.73%92M-48.13%97M-51.94%99M
Other non current liabilities 21.17%578M21.17%578M-11.30%471M-12.82%449M-10.33%486M-11.01%477M-11.01%477M-8.92%531M-14.59%515M-17.00%542M
Total non current liabilities 22.26%4.05B22.26%4.05B-19.45%2.7B-19.76%2.68B-6.85%3.14B-1.52%3.32B-1.52%3.32B-3.84%3.36B-4.97%3.35B-5.99%3.37B
Total liabilities 20.94%5.95B20.94%5.95B-0.47%5.09B-7.36%4.64B-10.36%4.76B-5.91%4.92B-5.91%4.92B-5.12%5.12B-6.04%5.01B2.65%5.31B
Shareholders'equity
Share capital 0.00%3M0.00%3M0.00%3M0.00%3M0.00%3M0.00%3M0.00%3M0.00%3M0.00%3M0.00%3M
-common stock 0.00%3M0.00%3M0.00%3M0.00%3M0.00%3M0.00%3M0.00%3M0.00%3M0.00%3M0.00%3M
-Preferred stock --0--0--0--0--0--0--0--0--0--0
Retained earnings -4.09%750M-4.09%750M74.10%773M55.71%1.09B96.12%1.06B141.36%782M141.36%782M219.42%444M337.50%700M240.25%541M
Paid-in capital 1.17%5.45B1.17%5.45B1.41%5.46B1.83%5.46B1.78%5.44B1.16%5.39B1.16%5.39B1.34%5.38B1.28%5.36B1.04%5.35B
Gains losses not affecting retained earnings 6.73%-305M6.73%-305M-22.14%-331M-19.50%-337M-12.86%-316M5.76%-327M5.76%-327M25.14%-271M15.32%-282M6.04%-280M
Total stockholders'equity 0.91%5.9B0.91%5.9B6.21%5.9B7.49%6.21B10.32%6.19B10.18%5.85B10.18%5.85B9.17%5.56B12.87%5.78B8.83%5.61B
Total equity 0.91%5.9B0.91%5.9B6.21%5.9B7.49%6.21B10.32%6.19B10.18%5.85B10.18%5.85B9.17%5.56B12.87%5.78B8.83%5.61B
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----------Unqualified Opinion--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data

Investment Theme Gene Editing
Gene Editing
Intraday-0.17%